COFCO Biotechnology Co., Ltd.

符号: 000930.SZ

SHZ

6.57

CNY

今天的市场价格

-21.1266
市盈率
-2.7465
PEG比率
12.13B
MRK市值
0.09%
DIV收益率

COFCO Biotechnology Co., Ltd. (000930-SZ) 财务报表

Q: 什么是 COFCO Biotechnology Co., Ltd. (000930.SZ) 总资产是多少？

COFCO Biotechnology Co., Ltd. (000930.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 COFCO Biotechnology Co., Ltd. (000930.SZ). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 COFCO Biotechnology Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	1481.1	1016.6	1116	662.3	700.5	772.9	554.8	617.8	537.1	284.5	255.9	353.4	406.6	508.6	694	552.7	734.7	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	29.2	1.3
balance-sheet.row.short-term-investments	2.1	3.8	-24.4	-21.1	-26.5	-26.4	0	5.5	0	-5.8	0.6	0.3	1.2	3.8	10	0	35.6	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	1549.6	2608.5	2147	4052.6	1726.9	2861.6	688.4	469.1	509.4	826.6	694.3	566.1	626.9	558.3	380.1	539.1	1019	968.9	731.6	510.3	580.8	225.8	189.4	57.2	36.2	26.7	35.4	42
balance-sheet.row.inventory	2534.3	3763.2	4052.3	4991.5	2770	3867.3	619.1	563.4	737.8	1265.4	923	1188.3	773.6	982.5	625.3	843.3	709.6	594.6	951.6	619.2	332.6	170.8	69.2	78	40.6	36.7	28.2	23.8
balance-sheet.row.other-current-assets	470.3	282.6	319.1	195	1530.5	1904.7	36.3	21.2	31.8	-189.4	-208.7	-100.9	-92.3	-70.4	-29.5	-53.9	-174.6	141.4	-48.6	-22.3	35.9	111.1	119.4	228.6	302.1	119.4	47.6	22.7
balance-sheet.row.total-current-assets	6035.3	7671	7634.4	9901.4	6727.9	9406.5	1898.6	1671.5	1816	2187.1	1664.5	2007	1714.7	1979	1669.8	1881.2	2288.8	2029.6	2255.2	1670.1	1536.2	869.4	684.5	525.9	624.2	244.8	140.3	89.9
balance-sheet.row.property-plant-equipment-net	8678	8612	8650	8493.8	8394.1	8774.9	3397.5	3130.4	3315.9	4225.7	4420.6	4371	4283.5	4455.1	4607.6	5034.4	5065.8	5229.5	4696.8	4034.1	3001.4	2095.1	1680.8	779	431.6	245.8	167.3	100.8
balance-sheet.row.goodwill	366	366	366	366	366	366	366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	602.7	610.6	629.7	852.7	823.9	898.9	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	968.7	976.6	995.8	1218.8	1189.9	1265	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.long-term-investments	535.4	536.9	536.6	538.5	592.2	610.6	39.1	33.6	0	44.9	38.5	38.8	37.9	35.3	56.4	0	39.4	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	265	164.5	202.8	133.3	131.7	131.9	118.9	9.3	0	46.2	40.4	35.1	45.2	73	63.6	38.1	55.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	75.5	139.2	42.6	198.8	121	98.7	56.3	257.2	173.7	19.4	30.8	39.2	41.8	4.7	10.3	73.7	35.6	290.4	383.3	179	170.6	69.7	82.5	47	24.5	0	0	0
balance-sheet.row.total-non-current-assets	10522.5	10429.3	10427.7	10583.1	10429	10881	4057.3	3763.5	3832.2	4677.1	4886.9	4852.2	4762.6	4943.9	5096.9	5322.9	5357.8	5658.8	5137.3	4229.9	3180.8	2170.7	1763.3	826	456.1	245.8	167.3	100.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.account-payables	681.9	919.6	920.2	845.8	854.8	984.9	315.1	309	197.3	582.2	332.6	287.8	278.3	476	564	1268	1652.7	1326.8	1511.4	1316.5	912.6	511.8	376.8	276.9	132.9	100.8	63	36.7
balance-sheet.row.short-term-debt	3398.9	2929.1	2871.7	6640.2	2731.4	5158.9	2261.2	2126.9	2461.3	2118	1908.5	2203.6	2343.1	2965.7	2986	3035.9	2781.9	2432.8	2343.8	1802.3	1413.2	783.9	389.2	198.7	139.8	58.8	52	39.7
balance-sheet.row.tax-payables	47.6	91.4	64.5	119.9	78.5	119.9	46.1	42.1	24.3	6.3	18.4	-22.6	-1.9	-13	64.1	-9.9	-50.5	-6.5	5.7	-26.3	-38.3	-11.8	-8.2	34.1	36.2	27.5	12.7	8.3
balance-sheet.row.long-term-debt-total	165.6	296.9	523.7	189.7	274.7	645	535.3	377.8	564.1	688.3	779.1	853.1	373	413.6	562.3	603	983	1110	591.3	884.9	630.2	190.5	115.2	170.2	178.2	112.3	65.8	19.9
Deferred Revenue Non Current	56.5	59	50.9	64.5	67.5	62.6	18	18.9	20.6	44.2	48.2	0	0	0	0	0	-912.9	0	0	0	0	0	0	0	-178.2	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	794.7	1034.1	32.4	55.9	1633.6	3541.2	33.1	37	19.9	45.2	58.2	54.3	58.8	63.5	37.3	44.8	66.4	544.3	95.2	55.9	28.4	15.1	3.7	3.3	1.8	0.8	0.9	2.1
balance-sheet.row.total-non-current-liabilities	492.5	427.3	712.9	359.3	412.7	836.9	741.2	944.7	1108	754.6	831	942.7	617.2	438.9	592.2	616.9	1054.4	1177.6	591.4	889.5	637.2	191.2	116.3	173.6	183.9	112.3	65.8	19.9
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	196.6	105.6	117.3	121.7	17.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	5634.3	5588.8	6303.4	9682.7	6954	10641.7	3994.5	3729.2	4074.5	3760.4	3457.9	3790	3538.7	4321.2	4425	5169.6	5734.5	5667.4	4957.5	4111.9	3105.2	1534.1	1067.2	759.8	508.4	340.3	208.6	122.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1864.7	1865.3	1865.7	1865.8	1847.6	1847.6	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964	391.9	318.6	318.6	177	147	147	87	44.8	43
balance-sheet.row.retained-earnings	1411.7	3152.3	2601.3	1645.1	1060.4	514.4	-278.2	-500.4	-627.5	809.8	802.4	788.9	676.3	390.2	185.5	-50.2	-108.5	-50	339.6	273.4	273.4	192.4	127.2	56.2	49	15.6	46.1	21.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	1226.6	1131.5	989.9	888.8	996.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	5948.5	5950.8	5940.4	5994	5923	6864.1	1117.6	1096.9	1098.7	1114.6	1105.4	1086.3	1074.9	1027.8	973.4	931.5	960.1	1002.6	993.8	1080	997.9	979.2	1065.8	388.9	376	47.7	8.1	3.7
balance-sheet.row.total-stockholders-equity	10451.6	12099.9	11397.4	10393.7	9827.4	9226.1	1803.8	1560.9	1435.6	2888.9	2872.2	2839.7	2715.7	2382.4	2123.3	1845.8	1816	1917	2297.5	1745.3	1589.9	1490.1	1370.1	592.1	571.9	150.3	99	67.9
balance-sheet.row.total-liabilities-and-stockholders-equity	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.minority-interest	402	411.6	361.3	408.1	375.5	419.8	157.6	144.9	138.2	214.9	221.3	229.4	223.1	219.3	218.4	188.7	96.1	104.1	137.6	42.8	21.9	15.9	10.5	0	0	0	0	0
balance-sheet.row.total-equity	10853.6	12511.5	11758.7	10801.8	10202.9	9645.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	535.4	536.9	512.1	517.3	565.7	584.2	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	66.4	73.7	74.9	290.4	383.3	179	170.6	69.7	82.3	47	24.5	0	0	0
balance-sheet.row.total-debt	3761.1	3226	3395.4	6829.9	3006.1	5804	2796.5	2504.7	3025.3	2806.3	2687.6	3056.8	2716.1	3379.3	3548.3	3638.9	3764.9	3542.8	2935.1	2687.2	2043.4	974.4	504.4	368.9	318	171.1	117.8	59.5
balance-sheet.row.net-debt	2280	2209.4	2279.5	6167.6	2305.6	5031	2241.7	1892.4	2488.3	2521.8	2432.3	2703.7	2310.8	2874.5	2864.3	3086.3	3065.7	3218.1	2314.6	2124.4	1456.4	612.7	197.9	206.8	72.7	109.2	88.6	58.2

现金流量表

在 COFCO Biotechnology Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	1060.9	1133	628.2	558.9	517.4	249.7	133.2	-1495	31.6	50.5	201.5	361.3	301.2	279.9	61.7	17.3	-384.8	139.1	107.1	104.7	114.1	110	86	40.6	15.6
cash-flows.row.depreciation-and-amortization	458.2	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6
cash-flows.row.deferred-income-tax	36.1	-62.2	-3.3	-0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-5	62.2	3.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1261.9	2701.8	-4471.1	1670.7	-2886.4	88	340.8	190.7	-233.6	254.1	-384.4	-185.6	-477.1	-324.4	-233	675.7	-270.7	-95.3	23	-79.6	-10.4	-80.2	-16	-251.5	-22
cash-flows.row.account-receivables	-1051.9	2418.2	-2276.3	960.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	83.1	760.3	-2462.3	983.4	-1741.4	-117.8	257	418.1	-289.3	264.8	-413.8	179.8	-357.2	218.1	-133.8	-115	357	-332.4	-286.5	-161.9	-101.3	-22.7	-37.3	-3.9	0
cash-flows.row.account-payables	-329.1	-414.5	270.7	-273	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.1	-62.2	-3.3	-0.5	-1145	205.8	83.7	-227.3	55.6	-10.7	29.5	-365.3	-119.9	-542.5	-99.2	790.7	-627.7	237.1	309.5	82.3	90.9	-57.5	21.4	-247.6	0
cash-flows.row.other-non-cash-items	420.1	560.4	495.7	994.9	836.3	228.9	142.5	914.3	137.3	176.6	209.7	258	239	366.7	387.4	126	428	134.2	81.5	46.2	25.2	20.2	25.7	51.5	21.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.acquisitions-net	305.7	160.5	107.8	151.7	0	7449.1	0	0	0	0	-19.7	0	0	0.5	0	337.2	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-32.6	270.4	-21.1	-32	0	-6740.9	0	0	0	0	170.9	0	0	-30.7	0	-45	-2.3	-354.3	-35.6	-238	-3.8	-58.5	-22.5	-17.5	0
cash-flows.row.sales-maturities-of-investments	14.8	1.6	6.3	106.7	47.2	2.2	5.8	5.8	5.7	3.7	3.7	3.7	32.2	6.7	5.7	191.9	2.3	8	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-22.7	9.4	-4.5	44	-33.5	-639.2	13.8	0.6	1.2	7.9	-160.7	8.8	1.3	33.5	32.3	-337.2	107	10.2	-92.2	111.9	0.9	0.2	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-300.6	-667.9	-899	-630.4	-854.7	-568	-140.9	-77.5	-122.6	-229.1	-166.5	-137.5	-145	-152.5	-205.8	-190.3	-337.8	-1062.3	-831.2	-917	-506.2	-736.5	-182.9	-189	-7.2
cash-flows.row.debt-repayment	-6493.2	-11592.7	-5566.1	-8894.5	-7613.7	-2708.1	-3325.4	-3293.6	-3140.6	-2970.4	-3654.9	-3599.2	-4020.9	-3431	-3059.1	-3342.8	-2557.6	-1954.6	-2032.2	-1003.6	-797.2	-268.2	-170.9	-192.9	-38.7
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-554.7	-277.3	-164.4	-196	-191.5	-114.7	-131.3	-180.7	-166.1	-181.8	-212.7	-200.4	-197.6	-242.6	-302	-233.8	-206.1	-137.7	-118.6	-73.7	-41.3	-25.9	-90.6	-14.1	-7.8
cash-flows.row.other-financing-activites	6453.7	8168.4	9485.1	6000.6	9127.9	2588	2895.5	3895.4	3253.9	2550.8	3715.9	3150.3	3878.2	3367.9	2989.2	3064.9	2741.1	2829.9	2619.7	2068.7	1208.9	1083.1	234.4	723.7	79.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-594.3	-3701.7	3754.6	-3089.9	1322.7	-234.8	-561.2	421	-52.9	-601.3	-151.7	-649.3	-340.3	-305.7	-371.8	-511.7	-22.6	737.6	468.9	991.3	370.3	789	-27.1	516.7	32.6
cash-flows.row.effect-of-forex-changes-on-cash	40.4	-4.3	-0.5	1.4	5.7	0.5	2.3	-4.8	-2.1	-5.1	-2.8	-6.6	-7.2	0.1	-7.6	-8.8	-7.2	-2.8	-0.1	6.5	0.9	0.2	0	0	0
cash-flows.row.net-change-in-cash	-146.1	467.7	-55.8	-69.2	-449.6	-54.7	85	224.6	29.2	-97.8	-52.2	-99.5	-179.1	131.3	-146.5	374.5	-295.8	57.6	-24.1	225.3	55.2	144.4	-83.1	183.4	44.9
cash-flows.row.cash-at-end-of-period	963	1109.1	641.4	697.2	766.4	539.4	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9
cash-flows.row.cash-at-beginning-of-period	1109.1	641.4	697.2	766.4	1216	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	16.9
cash-flows.row.operating-cash-flow	708.4	4841.6	-2910.9	3649.7	-923.3	747.7	784.7	-114.2	206.8	737.7	268.7	693.9	313.3	589.4	438.7	1085.3	71.7	385.2	338.3	144.4	190.1	91.7	126.8	-144.2	19.5
cash-flows.row.capital-expenditure	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.free-cash-flow	142.7	3731.8	-3898.4	2748.9	-1791.7	108.4	624.2	-198.1	77.2	497.1	108	544	134.9	427	194.8	748.1	-373	-341	-365.1	-646.5	-313.1	-586.4	-33.6	-315.8	12.3

利润表行

COFCO Biotechnology Co., Ltd. 的收入与上期相比变化了 NaN%。据报告, 000930.SZ 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	20289.8	19918.1	23468.6	19909.4	19472	17703.9	6275.9	5603.4	6457.3	7153.2	7339.9	7730.4	7401.3	5967.2	5011	4801.9	4178.1	4398.2	3261.3	2198.2	1547.4	1199.4	853.2	705.2	482.9	345.6	229	102.2
income-statement-row.row.cost-of-revenue	19341.4	17666.6	20842.8	17827.7	16735.5	14803.5	5596.5	4830.8	6482.2	6463.1	6652.7	6955.5	6695.1	5758.5	4752.4	4864.9	4471	4424.6	2922	1807.2	1260.9	954.2	660.1	503.9	381.8	268.8	169.5	69.5
income-statement-row.row.gross-profit	948.4	2251.5	2625.7	2081.7	2736.5	2900.5	679.4	772.5	-25	690.1	687.2	774.9	706.2	208.7	258.6	-63.1	-292.9	-26.4	339.4	391.1	286.5	245.2	193.1	201.3	101.1	76.8	59.5	32.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.operating-expenses	1403.8	553.1	752.6	860	1130	1516.3	297	607.3	588	604.1	636.2	668.1	597.7	517.7	437.6	429.5	361.5	438.9	208.9	158	96.9	89.7	75.9	77.3	42.3	25.8	18.2	9.6
income-statement-row.row.cost-and-expenses	20745.3	18219.7	21595.5	18687.7	17865.5	16319.7	5893.6	5438.1	7070.2	7067.2	7288.9	7623.6	7292.8	6276.2	5190	5294.4	4832.5	4863.5	3130.8	1965.2	1357.7	1043.9	735.9	581.2	424.1	294.6	187.7	79.1
income-statement-row.row.interest-income	16.2	16.2	15.4	10.6	9.9	5	2.1	4.1	4.6	3.2	5.1	4.2	7.3	5.4	5.5	8	36.2	37.6	12.8	5.3	5.9	2.5	7.1	2.3	0	0	0	0
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.total-operating-expenses	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.depreciation-and-amortization	509.2	888.7	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6	6.7	4.1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-455.4	1350.2	1926.6	1195.5	1656.4	614.2	154.9	-57.8	-1547.6	-57.1	-144	-96.8	-144.2	-557.7	-539.8	-802.8	-780	-687.9	26.9	159.2	146.6	133.5	102.7	99.3	47.3	41.8	34.6	19
income-statement-row.row.income-before-tax	-539.7	1359.9	1383.1	801.9	666.3	617.8	259.1	135.9	-1474.1	59.7	54.1	265	498.2	331.3	324	68.6	39.4	-351.5	226	160.9	145	165.1	120.1	101.2	47.8	42.9	34.5	19
income-statement-row.row.income-tax-expense	73.8	298.9	250.1	173.8	107.5	100.4	9.4	2.6	20.9	28.1	3.7	63.6	136.9	59.9	44.1	34.7	22.2	30.9	70.2	53.8	40.3	51	10.1	15.2	7.2	6.4	5.2	2.9
income-statement-row.row.net-income	-601.6	1058.5	1129.6	593.1	592.8	483	237.3	127.1	-1418	35.2	50.7	183	355.1	263.9	251.9	26.4	25.8	-384.8	139.1	101.1	98.8	110.2	110	86	40.6	36.5	29.3	16.2